series-a
Stage
About
X37 is an AI-driven drug discovery company that uses machine learning to design therapeutics targeting difficult-to-target proteins. The company focuses on developing programs across areas including oncology, autoimmune diseases, and anticoagulation.
Explore X37's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.